Augmenting drug–carrier compatibility improves tumour nanotherapy efficacy

por Zhao, Yiming, Fay, François, Hak, Sjoerd, Manuel Perez-Aguilar, Jose, Sanchez-Gaytan, Brenda L., Goode, Brandon, Duivenvoorden, Raphaël, de Lange Davies, Catharina, Bjørkøy, Astrid, Weinstein, Harel, Fayad, Zahi A., Pérez-Medina, Carlos, Mulder, Willem J. M.
Publicado 2016